Philip Ph G. De Groot
#135,269
Most Influential Person Now
Philip Ph G. De Groot's AcademicInfluence.com Rankings
Philip Ph G. De Grootbiology Degrees
Biology
#9219
World Rank
#12397
Historical Rank
Immunology
#548
World Rank
#566
Historical Rank
Neuroscience
#1333
World Rank
#1378
Historical Rank
Download Badge
Biology
Philip Ph G. De Groot's Degrees
- PhD Immunology University of Amsterdam
- Masters Biomedical Sciences University of Amsterdam
- Bachelors Biology University of Amsterdam
Similar Degrees You Can Earn
Why Is Philip Ph G. De Groot Influential?
(Suggest an Edit or Addition)Philip Ph G. De Groot's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) (2006) (4892)
- Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. (2002) (1813)
- Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines (2003) (743)
- Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2). (2002) (660)
- Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients (2009) (585)
- Structures of Glycoprotein Ibα and Its Complex with von Willebrand Factor A1 Domain (2002) (545)
- Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? (1993) (523)
- Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity (2006) (519)
- A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. (1983) (445)
- IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. (2005) (379)
- Nitric Oxide Functions as an Inhibitor of Platelet Adhesion Under Flow Conditions (1992) (348)
- Adhesion mechanism of human β2‐glycoprotein I to phospholipids based on its crystal structure (1999) (344)
- Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. (2010) (313)
- Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients (2008) (306)
- F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. (2012) (304)
- Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. (2001) (285)
- Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. (2004) (271)
- The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study (2009) (268)
- Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. (1999) (262)
- Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. (2008) (257)
- Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). (1994) (255)
- Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. (2010) (254)
- Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. (1993) (250)
- Glycation Induces Formation of Amyloid Cross-β Structure in Albumin* (2003) (242)
- Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. (2009) (240)
- Von Willebrand factor in the vessel wall mediates platelet adherence. (1985) (238)
- beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. (2004) (232)
- Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′* (2003) (229)
- 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. (2014) (224)
- Haemostatic abnormalities in patients with liver disease. (2002) (222)
- The Complexity of the Phospholipid Binding Protein Annexin V (1995) (219)
- Lupus anticoagulants and the risk of a first episode of deep venous thrombosis (2005) (215)
- Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. (2006) (198)
- Increased platelet deposition on atherosclerotic coronary arteries. (1994) (192)
- Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. (2011) (183)
- Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions. (2008) (174)
- Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. (2002) (165)
- A3 Domain Is Essential for Interaction of von Willebrand Factor with Collagen Type III (1996) (165)
- A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. (1992) (163)
- The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. (1983) (160)
- P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. (2006) (156)
- Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. (1988) (155)
- Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. (1982) (151)
- A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. (2005) (148)
- The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. (2003) (139)
- Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. (1990) (138)
- Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations. (2016) (133)
- Role of ADP Receptor P2Y12 in Platelet Adhesion and Thrombus Formation in Flowing Blood (2002) (130)
- The significance of autoantibodies against β2-glycoprotein I. (2012) (129)
- Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa. (1985) (128)
- Subendothelial Proteins and Platelet Adhesion: von Willebrand Factor and Fibronectin, Not Thrombospondin, Are involved in Platelet Adhesion to Extracellular Matrix of Human Vascular Endothelial Cells (1986) (122)
- Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. (2007) (122)
- An Experimental Model to Study the in Vivo Survival of von Willebrand Factor (2004) (119)
- Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. (2004) (119)
- Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome (2006) (118)
- A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. (2006) (117)
- Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. (2003) (115)
- Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis (2008) (115)
- beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. (2007) (115)
- Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. (2007) (113)
- Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. (2011) (113)
- The binding of high molecular weight kininogen to cultured human endothelial cells. (1988) (112)
- Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis (2020) (109)
- Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. (2010) (109)
- Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis (2007) (106)
- Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses (2013) (105)
- Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1. (1985) (105)
- Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant. (1990) (104)
- Factor VIII half-life and clinical phenotype of severe hemophilia A. (2005) (101)
- β₂-glycoprotein I: a novel component of innate immunity. (2011) (101)
- The obstetric antiphospholipid syndrome. (2006) (99)
- Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. (1984) (96)
- A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia. (2008) (94)
- Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. (2000) (93)
- Increased Thromboxane Biosynthesis in Patients With Acute Cerebral Ischemia (1993) (92)
- Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin. (1994) (91)
- ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. (2009) (89)
- Cigarette Smoke Impairs Endothelial Cell Prostacyclin Production (1986) (89)
- Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium. (1984) (88)
- The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. (2011) (88)
- A simple method to discriminate between β2‐glycoprotein I‐ and prothrombin‐dependent lupus anticoagulants (2003) (87)
- Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. (2008) (86)
- Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men. (2010) (85)
- Immune responses against domain I of β(2)-glycoprotein I are driven by conformational changes: domain I of β(2)-glycoprotein I harbors a cryptic immunogenic epitope. (2011) (85)
- Platelet adhesion to collagen type IV under flow conditions. (1996) (83)
- Thrombin-induced release of von Willebrand factor from endothelial cells is mediated by phospholipid methylation. Prostacyclin synthesis is independent of phospholipid methylation. (1984) (83)
- Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via alpha2 beta1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces. (1998) (81)
- Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia. (2013) (81)
- Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib. (1995) (80)
- Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. (2006) (80)
- Isolation of a storage and secretory organelle containing Von Willebrand protein from cultured human endothelial cells. (1984) (79)
- High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood. (1990) (78)
- The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. (2008) (78)
- Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels. (2007) (78)
- Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. (2000) (77)
- Interference with the Host Haemostatic System by Schistosomes (2013) (77)
- Platelet adhesion to laminin: role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. (1992) (76)
- Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability. (2012) (76)
- Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study. (1998) (75)
- Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen. (1988) (75)
- Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. (1995) (74)
- Complexes of anti‐prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces (2001) (74)
- Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C. (1993) (74)
- beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. (2004) (74)
- Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation (2002) (74)
- Dimers of β2-Glycoprotein I Mimic thein Vitro Effects of β2-Glycoprotein I-Anti-β2-glycoprotein I Antibody Complexes* (2001) (74)
- Plasmin Cleavage of von Willebrand Factor as an Emergency Bypass for ADAMTS13 Deficiency in Thrombotic Microangiopathy (2014) (73)
- Glycation induces formation of amyloid cross-beta structure in albumin. (2003) (73)
- Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men (2009) (71)
- Interaction of blood platelets with the vessel wall. (1988) (70)
- Reconstitution of the vascular wall in vitro. A novel model to study interactions between endothelial and smooth muscle cells. (1986) (69)
- Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts. (1981) (69)
- Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B. (2010) (68)
- Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells. (1985) (68)
- Antibodies to platelets in patients with anti-phospholipid antibodies. (1991) (68)
- Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation. (1994) (68)
- Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity (2014) (67)
- Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13 (2012) (67)
- Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. (1993) (67)
- Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects. (1987) (66)
- The Binding Site in β2-Glycoprotein I for ApoER2′ on Platelets Is Located in Domain V* (2005) (66)
- Plasma Protein β-2-Glycoprotein 1 Mediates Interaction between the Anti-tumor Monoclonal Antibody 3G4 and Anionic Phospholipids on Endothelial Cells* (2006) (66)
- High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterization. (1988) (66)
- Prevalence of antiphospholipid antibodies in patients with fetal loss. (1991) (66)
- The presence of active von Willebrand factor under various pathological conditions (2007) (65)
- A new perfusion chamber to detect platelet adhesion using a small volume of blood. (1998) (65)
- Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets. (2014) (64)
- Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. (1992) (63)
- Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor (2012) (63)
- The impact of the fibrinolytic system on the risk of venous and arterial thrombosis. (2009) (63)
- Interplay between platelets and coagulation (2020) (62)
- Storage and secretion of von Willebrand factor by endothelial cells. (1988) (61)
- Risk factors for thrombosis in lupus patients. (1989) (61)
- Annexin A5 polymorphism (−1C→T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome (2006) (61)
- Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis (2015) (61)
- Identification of Coagulation Factor XI as a Ligand for Platelet Apolipoprotein E Receptor 2 (ApoER2) (2009) (61)
- Platelet function alterations in dengue are associated with plasma leakage (2014) (60)
- Regulation of von Willebrand factor-platelet interactions (2010) (60)
- Absence of Fibrinogen in Afibrinogenemia Results in Large but Loosely Packed Thrombi under Flow Conditions (2001) (60)
- Pregnancy in Systemic Lupus Erythematosus: a Prospective Study (1994) (60)
- β2-Glycoprotein I Is Proteolytically Cleaved In Vivo upon Activation of Fibrinolysis (1999) (59)
- Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets (1987) (58)
- Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. (2010) (58)
- Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. (1989) (57)
- Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor. (1996) (56)
- Treatment of Uremic Anemia with Recombinant Erythropoietin also Reduces the Defects in Platelet Adhesion and Aggregation Caused by Uremic Plasma (1991) (56)
- New Insights into the Role of Erythrocytes in Thrombus Formation (2013) (55)
- Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa. (1991) (54)
- Antiphospholipid Syndrome–Not a Noninflammatory Disease (2015) (54)
- Inhibition of Platelet Adhesion to Fibrin(ogen) in Flowing Whole Blood by Arg-Gly-Asp and Fibrinogen γ-Chain Carboxy Terminal Peptides (1992) (51)
- Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts. (2014) (51)
- Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. (1994) (50)
- Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men (2009) (50)
- Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy (2010) (49)
- Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. (1990) (49)
- Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma. (1991) (49)
- Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients (2006) (49)
- Is asymptomatic malaria really asymptomatic? Hematological, vascular and inflammatory effects of asymptomatic malaria parasitemia. (2015) (48)
- The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. (1998) (48)
- Platelet aggregation: involvement of thrombin and fibrin(ogen). (2005) (48)
- The proteome of the insoluble Schistosoma mansoni eggshell skeleton. (2011) (48)
- Antiphospholipid antibodies--we are not quite there yet. (2011) (47)
- Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses (2015) (47)
- On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood. (1995) (47)
- Role of plasma viscosity in platelet adhesion. (1992) (46)
- Regional localization of the genes coding for human ACO2, ARSA, and NAGA on chromosome 22. (1980) (46)
- FLow-Induced PRotrusions (FLIPRs): A Platelet-Derived Platform for the Retrieval of Microparticles by Monocytes and Neutrophils (2014) (46)
- Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome. (2014) (45)
- Shear-stress-induced detachment of blood platelets from various surfaces. (1997) (45)
- Fibrinolysis and the risk of venous and arterial thrombosis (2007) (44)
- Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. (1992) (44)
- Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV. (1994) (44)
- Binding of von Willebrand Factor to Collagen Type III: Role of Specific Amino Acids in the Collagen Binding Domain of vWF and Effects of Neighboring Domains (2000) (43)
- Twenty-two years of failure to set up undisputed assays to detect patients with the antiphospholipid syndrome. (2008) (43)
- A fifty percent reduction of platelet surface glycoprotein Ib does not affect platelet adhesion under flow conditions. (1998) (43)
- von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets. (1989) (43)
- Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages (2007) (42)
- Salvianolic acid B inhibits platelet adhesion under conditions of flow by a mechanism involving the collagen receptor alpha2beta1. (2008) (42)
- Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma (2010) (42)
- Arachidonate metabolism in cultured human vascular endothelial cells. Evidence for two prostaglandin synthetic pathways sensitive to acetylsalicylic acid. (1982) (41)
- Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin. (1996) (40)
- The antibacterial activity of peptides derived from human beta‐2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes (2008) (40)
- Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis (2005) (40)
- Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flow. (1997) (40)
- Ternary vitronectin-thrombin-antithrombin III complexes in human plasma. Detection and mode of association. (1993) (40)
- Effect of Extracellular Matrix Glycation on Endothelial Cell Adhesion and Spreading: Involvement of Vitronectin (1997) (40)
- von Willebrand factor and the blood vessel wall. (1991) (39)
- Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin. (2004) (39)
- Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network* (2014) (39)
- Thrombopoietin increases platelet adhesion under flow and decreases rolling (2003) (38)
- The (non‐)sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome (2020) (38)
- Up-regulation of platelet activation in hemophilia A (2011) (38)
- Platelet interaction with the vessel wall. (2012) (37)
- Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high-risk women. (2000) (37)
- Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men. (2009) (37)
- Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA. (1990) (37)
- Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood. (1994) (37)
- Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs (2013) (36)
- Characterization of the Philadelphia chromosome by gene mapping. (1981) (36)
- Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers (2013) (36)
- Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I (2010) (36)
- Antiphospholipid antibodies: update on detection, pathophysiology, and treatment (2004) (36)
- Induction of anti‐β2‐glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes (2011) (36)
- Shear-Resistant Binding to von Willebrand Factor Allows Staphylococcus lugdunensis to Adhere to the Cardiac Valves and Initiate Endocarditis. (2016) (35)
- The Inter-Relationship of Platelets with Interleukin-1β-Mediated Inflammation in Humans (2018) (35)
- Comparison of Platelet Interaction with Subendothelium of Human Renal and Umbilical Arteries and the Extracellular Matrix Produced by Human Venous Endothelial Cells (1984) (35)
- Strenuous exercise induces a hyperreactive rebalanced haemostatic state that is more pronounced in men (2016) (35)
- Elevated Plasma Surfactant Protein D (SP‐D) Levels and a Direct Correlation with Anti‐severe Acute Respiratory Syndrome Coronavirus‐specific IgG Antibody in SARS Patients (2009) (34)
- Role of von Willebrand factor in the vessel wall. (1987) (34)
- Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting activated factor X, but not by those inhibiting thrombin or tissue factor (2003) (34)
- Thrombogenicity and procoagulant activity of human mesothelial cells. (1992) (33)
- Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow (2014) (33)
- New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats (2018) (32)
- Glycoprotein Ibα–Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin Under Conditions of Flow (2005) (32)
- From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome. (2013) (32)
- Fibrinogen and high molecular weight fibrinogen during and after normal pregnancy. (2004) (32)
- The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies. (1998) (31)
- von Willebrand Factor without the A2 Domain Is Resistant to Proteolysis (1997) (31)
- A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia (2009) (31)
- Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue (2019) (31)
- Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation. (2004) (30)
- Platelet adhesion to fibrin(ogen). (1993) (30)
- Increased high molecular weight fibrinogen in pre-eclampsia. (2003) (29)
- Thrombogenicity of the human arterial wall after interventional thermal injury. (1996) (29)
- Thrombin regulation by physiological inhibitors: the role of vitronectin. (1996) (29)
- A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans. (2008) (29)
- Interleukin‐l Inhibits the Synthesis of von Willebrand Factor in Endothelial Cells, Which Results in a Decreased Reactivity of Their Matrix toward Platelets (1987) (29)
- Cyclotriveratrylene (CTV) as a new chiral triacid scaffold capable of inducing triple helix formation of collagen peptides containing either a native sequence or Pro-Hyp-Gly repeats. (2002) (29)
- Higher platelet reactivity and platelet-monocyte complex formation in Gram-positive sepsis compared to Gram-negative sepsis (2017) (29)
- Internalization of Vitronectin-Thrombin-Antithrombin Complex by Endothelial Cells Leads to Deposition of the Complex into the Subendothelial Matrix (*) (1995) (28)
- Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation. (2001) (28)
- FRETS‐VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura (2006) (28)
- Tests for lupus anticoagulant revisited. (2004) (28)
- Vessel wall proteins adhesive for platelets. (1991) (28)
- Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy. (2005) (28)
- Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution (1987) (27)
- The Lupus Anticoagulant Paradox (2017) (27)
- Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A (2003) (27)
- Platelet adhesion to cyanogen-bromide fragments of collagen alpha 1(I) under flow conditions. (1993) (27)
- Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor. (1996) (26)
- Evolutionary conservation of the lipopolysaccharide binding site of β2-glycoprotein I (2011) (26)
- Plasma fibrinogen inhibits platelets adhesion in flowing blood to immobilized fibrinogen. (1996) (26)
- Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWF. (2007) (26)
- Patient‐derived monoclonal antibodies directed towards beta2 glycoprotein‐1 display lupus anticoagulant activity (2011) (26)
- Thrombin‐activatable fibrinolysis inhibitor is degraded by Salmonella enterica and Yersinia pestis (2010) (25)
- The Future of Antiphospholipid Antibody Testing (2012) (25)
- Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity (2011) (25)
- Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation. (1997) (24)
- Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case–control study (2012) (24)
- Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome. (2017) (24)
- Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin. (2018) (24)
- The effect of recombinant IgG antibodies against the leucine-33 form of the platelet β3 integrin (HPA-1a) on platelet function (2004) (24)
- Platelet adhesion to collagen in healthy volunteers is influenced by variation of both alpha(2)beta(1) density and von Willebrand factor. (2000) (23)
- The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention (2011) (23)
- Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma? (2014) (23)
- β2‐Glycoprotein I is incorrectly named apolipoprotein H (2009) (22)
- Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13 (2015) (22)
- Contact System Activation on Endothelial Cells (2014) (22)
- Platelet Adhesion and Aggregate Formation in Type I Diabetes Under Flow Conditions (1991) (22)
- The influence of the pulsatility of the blood flow on the extent of platelet adhesion. (2008) (22)
- Differential platelet adhesion to distinct life‐cycle stages of the parasitic helminth Schistosoma mansoni (2007) (22)
- Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF). (1988) (22)
- Protein C Pathway, Antiphospholipid Antibodies and Thrombosis (1994) (21)
- Reduced platelet adhesion in flowing blood to fibrinogen by alterations in segment γ316–322, part of the fibrin‐specific region * (2002) (21)
- The ideal anti-thrombotic drug. (1992) (21)
- Beta2-glycoprotein I and LDL-receptor family members. (2004) (21)
- Platelet-monocyte interaction in Mycobacterium tuberculosis infection. (2018) (21)
- Quantification of fibrin deposition in flowing blood with peroxidase-labeled fibrinogen. High shear rates induce decreased fibrin deposition and appearance of fibrin monomers. (1991) (20)
- Effect of 2-deoxyglucose on lysosomal enzymes in cultured human skin fibroblasts. (1980) (20)
- Targeted Phosphotyrosine Profiling of Glycoprotein VI Signaling Implicates Oligophrenin-1 in Platelet Filopodia Formation (2013) (20)
- Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation on endothelial cells. The influence of thrombin on the reaction mechanism. (1991) (20)
- Anti-Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study. (2020) (20)
- Pathophysiology of antiphospholipid antibodies. (2004) (19)
- Adhesive Domains in the Collagen III Fragment α1(III)CB4 that Support α2β1- and von Willebrand Factor-mediated Platelet Adhesion under Flow Conditions (1999) (19)
- Platelet adhesion to vascular cells. The role of exogenous von Willebrand factor in platelet adhesion. (1990) (19)
- Chlamydia trachomatis Infection of Human Mesothelial Cells Alters Proinflammatory, Procoagulant, and Fibrinolytic Responses (1998) (19)
- Increased cytokine response after toll-like receptor stimulation in patients with stable coronary artery disease. (2013) (19)
- Antiphospholipid antibodies: specificity and pathophysiology. (1993) (18)
- Methylenetetrahydrofolate reductase 677 C/T genotype and cardiovascular disease mortality in postmenopausal women. (2001) (18)
- Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis. (2005) (18)
- Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation? (2000) (18)
- A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation (2016) (18)
- The role of thrombin in the regulation of the endothelial prostaglandin production. (1985) (17)
- Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome (2020) (17)
- Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery. (2013) (17)
- Recombinant vWF Type 2A Mutants R834Q and R834W Show a Defect in Mediating Platelet Adhesion to Collagen, Independent of Enhanced Sensitivity to a Plasma Protease (1999) (17)
- Platelet dysfunction contributes to bleeding complications in patients with probable leptospirosis (2017) (17)
- Cultured Endothelial Cells Regulate Platelet Adhesion to their Extracellular Matrix by Regulating its von Willebrand Factor Content (1995) (17)
- Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. (2013) (17)
- The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donors. (1994) (16)
- Factor V Arg506Gln mutation is not associated with cardiovascular mortality in older women. (1999) (16)
- The antiphospholipid syndrome: clinical characteristics, laboratory features and pathogenesis (2005) (16)
- Binding of von Willebrand factor and plasma proteins to the eggshell of Schistosoma mansoni. (2014) (16)
- SARS in Hong Kong. (2003) (15)
- Increased factor XIa levels in patients with a first acute myocardial infarction: the introduction of a new thrombin generation based factor XIa assay. (2014) (15)
- Suitability of low-molecular-weight heparin(oid)s and a pentasaccharide for an in vitro human thrombosis model. (1994) (15)
- Anti‐β2‐glycoprotein I and anti‐prothrombin antibodies cause lupus anticoagulant through different mechanisms of action (2021) (15)
- Detection of anti‐domain I antibodies by chemiluminescence enables the identification of high‐risk antiphospholipid syndrome patients: A multicenter multiplatform study (2019) (15)
- Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia (2021) (15)
- Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide. (1993) (15)
- Evidence that fibrin alpha-chain RGDX sequences are not required for platelet adhesion in flowing whole blood. (1995) (15)
- Clinical consequences of antiphospholipid antibodies. (2004) (14)
- Increased active von Willebrand factor during disease development in the aging diabetic patient population (2011) (14)
- Both increased and decreased platelet adhesion to thermally injured subendothelium is caused by denaturation of von Willebrand factor. (1993) (14)
- Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor (2019) (14)
- Tissue factor-independent effects of recombinant factor VIIa on hemostasis. (2008) (14)
- The antiphospholipid syndrome: clinical characteristics, laboratory features and pathogenesis. (2005) (13)
- Prolonged bleeding time and lupus anticoagulant: a second paradox in the antiphospholipid syndrome. (2004) (13)
- The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa. (2015) (13)
- Platelet Adhesion to Subendothelial Structures under Flow Conditions: No Effect of the Lipoxygenase Product 13-HODE (1989) (13)
- Fibrinogen and fibrin are novel substrates for Fasciola hepatica cathepsin L peptidases. (2018) (12)
- Oral anticoagulation reduces activated protein C less than protein C and other vitamin K-dependent clotting factors. (2002) (12)
- The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays (2017) (10)
- Antiphospholipid syndrome (2010) (10)
- Platelets as pivot in the antiphospholipid syndrome. (2014) (10)
- Thrombocytopenia and Platelet Dysfunction in Acute Tropical Infectious Diseases (2018) (10)
- Sustained pro-haemostatic activity of rFVIIa in plasma and platelets in non-bleeding pigs may explain the efficacy of a once-daily prophylaxis in humans (2014) (10)
- Lupus anticoagulant in cardiovascular diseases: the role of beta2-glycoprotein I. (2000) (10)
- A switch to a raltegravir containing regimen does not lower platelet reactivity in HIV-infected individuals (2018) (9)
- Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B (2010) (9)
- Increased Platelet Reactivity Is Associated with Circulating Platelet-Monocyte Complexes and Macrophages in Human Atherosclerotic Plaques (2014) (9)
- The Functions of the A1A2A3 Domains in Von Willebrand Factor Include Multimerin 1 Binding (2016) (9)
- beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome. (2002) (9)
- Increased Platelet-Monocyte Interaction in Stable COPD in the Absence of Platelet Hyper-Reactivity (2017) (9)
- Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II (2002) (9)
- Long-term treated HIV infection is associated with platelet mitochondrial dysfunction (2021) (9)
- Role of glycoprotein IIb:IIIa in the adhesion of platelets to collagen under flow conditions. (1997) (9)
- Interventional Thermal Injury of the Arterial Wall: Unfolding of von Willebrand Factor and Its Increased Binding to Collagen after 55° C Heating (1996) (9)
- Mechanisms of anti-phospholipid antibody formation and action. (2011) (9)
- Ascorbic Acid Increases the Thrombogenicity of Cellular Matrices (1991) (8)
- Haemostatic changes in urogenital schistosomiasis haematobium: a case-control study in Gabonese schoolchildren. (2019) (8)
- Platelet adhesion to the subendothelium under flow. (1999) (7)
- In Vitro Hemocompatibility Testing of Dyneema Purity Fibers in Blood Contact (2015) (7)
- Antiphospholipid Antibodies and the Risk of Stroke in Urban and Rural Tanzania: A Community-Based Case–Control Study (2016) (7)
- Endothelial and smooth muscle cells in the heart allograft response: isolation procedure and immunocytochemical features. (1991) (7)
- Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome? (2021) (7)
- [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura]. (2004) (6)
- The role of von Willebrand factor in platelet function. (2002) (6)
- Molecular basis of congenital afibrinogenaemia in a Dutch family (2003) (6)
- Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma (2018) (6)
- The Relationship between Fractional Flow Reserve, Platelet Reactivity and Platelet Leukocyte Complexes in Stable Coronary Artery Disease (2013) (6)
- Genome scan of clot lysis time and its association with thrombosis in a protein C‐deficient kindred (2011) (6)
- In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma. (1992) (6)
- Platelet degranulation and glycoprotein IIbIIIa opening are not related to bleeding phenotype in severe haemophilia A patients (2014) (6)
- Detection of the lupus anticoagulant in pregnancy. (1992) (6)
- The interaction of recombinant factor VIIa with platelet glycoprotein Ib. (2010) (6)
- β-radiation reduces the reactivity of extracellular matrix proteins in intravascular brachytherapy (IVBT), resulting in decreased platelet adhesion. (2012) (6)
- Higher and lower active circulating VWF levels: different facets of von Willebrand disease (2015) (5)
- Anti-phospholipid antibodies and vascular pathology. (1994) (5)
- The presence of anti-beta 2-glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis. (1996) (5)
- Annexin A5 haplotypes in the antiphospholipid syndrome. (2015) (5)
- Active von Willebrand factor and the risk of stroke. (2010) (5)
- The influence of hypoxia on platelet function and plasmatic coagulation during systemic inflammation in humans in vivo (2018) (5)
- Loss of blood platelet adhesion after heating native and cultured human subendothelium to 100 degrees Celcius. (1990) (5)
- Successful soft and hard tissue augmentation with platelet‐rich fibrin in combination with bovine bone space maintainer in a delayed implant placement protocol in the esthetic zone: A case report (2019) (4)
- Platelet Integrin αIIbβ3 Activation is Associated with 25-Hydroxyvitamin D Concentrations in Healthy Adults (2020) (4)
- Nature of the fibrinogen Aalpha gene TaqI polymorphism. (2001) (3)
- Endothelial cell-mediated thrombin formation. (1992) (3)
- Localization of a gene for human alpha-galactosidase B (= n-acetyl-alpha-d-galactosaminidase) on chromosome 22. (1978) (3)
- Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence. (2021) (3)
- Internalization of antithrombin III by cultured human endothelial cells and its subcellular localization. (1989) (3)
- Mutations on fibrinogen (gamma 316-322) are associated with reduction in platelet adhesion under flow conditions. (2001) (3)
- Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cells (2021) (3)
- Implant stability in patients treated with platelet‐rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors (2019) (3)
- Impaired platelet adhesion to lysed fibrin, whereas neutrophil adhesion remains intact under conditions of flow (2006) (3)
- Resonance frequency analysis with two different devices after conventional implant placement with ridge preservation: A prospective pilot cohort study. (2021) (3)
- Salivary tissue factor induces thrombin generation in a diurnal rhythm (2018) (3)
- Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans (2016) (3)
- Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation. (2020) (3)
- Plasmatic Coagulation Capacity Correlates With Inflammation and Abacavir Use During Chronic HIV Infection (2021) (3)
- Serotonin, key to thrombocytopenia in dengue? (2019) (2)
- AB0561 Needs-Assessment Survey for the Update of the Current Antiphospholipid Syndrome (APS) Classification Criteria (2015) (2)
- Response to letter regarding article, "plasmin cleavage of von willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy". (2015) (2)
- Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non‐genetic factors (2022) (2)
- Untargeted Plasma Metabolomics and Gut Microbiome Profiling Provide Novel Insights into the Regulation of Platelet Reactivity in Healthy Individuals (2021) (2)
- Kallikrein augments the anticoagulant function of the protein C system in thrombin generation (2021) (2)
- Inactivation by chloroquine of alpha-galactosidase in cultured human skin fibroblasts. (1981) (2)
- Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosis. (2007) (2)
- PRIMARY BINDING SITE OF VON WILLEBRAND FACTOR IN THE SUBENDOTHELIUM WHICH MEDIATES PLATELET ADHESION IS NOT COLLAGEN (1987) (1)
- Homozygosity for 807 T Polymorphism in &agr;2 Subunit of Platelet &agr;2&bgr;1 Is Associated With Increased Risk of Cardiovascular Mortality in High-Risk Women (2000) (1)
- Suppressing platelet microparticle formation by antibodies against platelet glycoprotein GPIb (2007) (1)
- The effects of signal transducer and activator of transcription three mutations on human platelets (2018) (1)
- KINETIC BEHAVIOUR OF VON WILLEBRAND FACTOR AND FIBRONECTIN EXPLAINS DEPENDENCE OF PLATELET ADHESION ON PHYSICAL PARAMETERS (1987) (1)
- Platelet-Vessel Wall Interaction (1993) (1)
- Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX? (2022) (0)
- [Adhesion of blood platelets. II. Adhesive proteins and their receptors: physiology and pathology]. (1989) (0)
- Increased active von Willebrand factor during disease development in the aging diabetic patient population (2011) (0)
- Platelet adhesion. (1995) (0)
- [Blood platelet adhesion. I. Adhesion to the vascular wall and the role of platelet transport]. (1989) (0)
- Further characterization of two forms of N-acetyl-alpha-galactosaminidase from human liver. (1978) (0)
- AUTHORS' REPLY (1994) (0)
- Brief Report on the 11th Meeting of the European Forum on Antiphospholipid Antibodies (2019) (0)
- Functional changes in hemostasis during asexual and sexual parasitemia in a controlled human malaria infection (2022) (0)
- PERTURBATION OF ENDOTHELIAL CELLS INDUCES THROMBIN FORMATION IN FLOWING BLOOD RESULTING IN PLATELET AGGREGATION ON THEIR MATRIX (1987) (0)
- Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability (2022) (0)
- The antiphospholipid syndrome finally fathomed? (2018) (0)
- No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury. (2018) (0)
- PLATELET ADHESION AND THROMBIN DEPENDENT AGGREGATION OF PATIENTS WITH AN UREMIC BLEEDING TENDENCY (1987) (0)
- Neural Network Diagnoses the Antiphospholipid Syndrome without Interrupting Anticoagulant Therapy (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Philip Ph G. De Groot?
Philip Ph G. De Groot is affiliated with the following schools:
